News

Additionally, data assessing fibroblast growth factor receptor-2 (FGFR-2) response to an FGFR antagonist in a novel FGFR-2 driven model were also presented. According to Aveo, preclinical data demonstrated

“We must hasten our progress against cancer by conducting exciting new science, which this year’s increase in funding, in addition to anticipated funds from the American Recovery and

The Agilent SureSelect Target Enrichment system, optimized for Illumina’s widely-adopted next-generation sequencing platform, the Genome Analyzer, provides researchers with a method for efficiently resequencing specific regions of interest

Ms Langouet has degrees in computer science and physiology. Since graduation her career has been in data management, programming, data systems and validation, process and change management, compliance

The combination of Hadasit’s oral immune modulation with Immuron’s existing oral protein and antibody technology could yield a convenient, all-natural, side-effect-free approach to address serious diseases including metabolic

“It is a pleasure for me to join the expert management and extended scientific team of Combimatrix Molecular Diagnostics. Array CGH testing has been the latest methodology to

The results of the study indicate that the product is bioequivalent to a leading antihypertensive product brand. The product has been developed using IntelGenx’s multilayer ‘Versatab’ delivery technology.

The partnership was formed as a key element of a strategic initiative for Sanwa Kagaku Kenkyusho (SKK) to target the Asian market, in step with SKK’s new medium-long

ChemDiv sees great potential in this acquisition by adding value to ChemDiv’s Discovery outSource services offered to pharmaceutical and biotech companies worldwide. Nikolay Savchuk, president and CEO of